US Patent Issued to MAYNE PHARMA on March 31 for "Halobetasol foam composition and method of manufacture thereof" (California, Massachusetts Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,100, issued on March 31, was assigned to MAYNE PHARMA LLC (Raleigh, N.C.).

"Halobetasol foam composition and method of manufacture thereof" was invented by Robert T. Gauthier (San Diego), James D. Hammer (Uxbridge, Mass.) and Wayne S. Alden IV (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a composition and method for treating various skin diseases. The composition is formulated as a foamable composition and includes the corticosteroid halobetasol."

The patent was filed on Aug. 19, 2019, under Application No. 16/544,070.

*For further information, including images, charts and tables, please visit: http://p...